| 000 | 01152 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517131234.0 | ||
| 264 | 0 | _c20170801 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1365-2710 | ||
| 024 | 7 |
_a10.1111/jcpt.12490 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarracedo-MartÃnez, E | |
| 245 | 0 | 0 |
_aTrends in celecoxib and etoricoxib prescribing following removal of prior authorization requirement in Spain. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacy and therapeutics _cApr 2017 |
||
| 300 |
_a185-188 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCelecoxib _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Utilization _xtrends |
| 650 | 0 | 4 | _aEtoricoxib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 |
_aSulfones _xtherapeutic use |
| 700 | 1 | _aPia-Morandeira, A | |
| 700 | 1 | _aFigueiras, A | |
| 773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 42 _gno. 2 _gp. 185-188 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcpt.12490 _zAvailable from publisher's website |
| 999 |
_c26704025 _d26704025 |
||